AP Perspectives 2024 ASH Annual Meeting & Exposition Burdens and QOL Impacts of Anemia and Transfusion Dependence in Myelofibrosis Lindsey E... December 19, 2024
AP Perspectives 2024 ASH Annual Meeting & Exposition Combination Interferon and Ruxolitinib vs Ruxolitinib in Myelofibrosis Lindsey E... December 19, 2024
AP Perspectives 2024 ASH Annual Meeting & Exposition Real-World Outcomes of Momelotinib as a Therapy Option in Myelofibrosis Patients With Anemia Lindsey E... December 19, 2024
AP Perspectives 2024 ASH Annual Meeting & Exposition Axatilimab for Chronic Graft-vs.-Host Disease Katie Sellers, MPAS, PA-C, reviews findings from the Agave-201 study presented at the ASH Annual Meeting, which evaluated axatilimab, an anti-CSF1R monoclonal antibody, in chronic graft-versus-host disease ( December 23, 2024
AP Perspectives 2024 ASH Annual Meeting & Exposition GVHD Prophylaxis: Ruxolitinib and De-escalated PTCy for Older Patients Katie Sellers, MPAS, PA-C, discusses a phase II trial presented at the ASH Annual Meeting exploring de-escalated post-transplant cyclophosphamide (PTCy) with ruxolitinib for GVHD prophylaxis in older patients undergoing reduced intensity conditioning allogeneic hematopoietic cell transplant ( December 26, 2024
AP Perspectives 2024 ASH Annual Meeting & Exposition PTCy is Standard of Care: Improved GVHD Control and Survival in Older Patients Katie Sellers, MPAS, PA-C, considers a post-hoc analysis focusing on transplant recipients aged ≥70 years in the BMT CTN 1703 trial ( December 26, 2024
Immediate Patient Access to Test Results and the Impact on Advanced Practitioners Beth Faiman, PhD, MSN, APRN-BC, AOCN®, BMTCN, FAAN, FAPO November 26, 2024
Obinutuzumab Infusion-Related Reactions Multicenter Retrospective Evaluation of Incidence, Severity, and Risk Factors Erin Hickey Zacholski, PharmD, BCOP, Sarah Rugh, PharmD Candidate, Jenna Marshall, PharmD Candidate, Et al. November 26, 2024
Pancreatic Cancer The Advanced Practitioners Role in Early Diagnosis and Management Lindsay Knox, FNP-C November 26, 2024
